The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
Open accessAbstract
Hyaluronan (HA) is a major glycosaminoglycan in the extracellular matrix whose expression is tightly linked to multidrug resistance and tumor progression. In this study we investigated HA-induced interaction between CD44 (a HA receptor) and Nanog (an embryonic stem cell transcription factor) in both human breast tumor cells (MCF-7 cells) and human ovarian tumor cells (SK-OV-3.ipl cells). Using a specific primer pair to amplify Nanog by reverse transcriptase-PCR, we detected the expression of Nanog transcript in both tumor cell lines. In addition, our results reveal that HA binding to these tumor cells promotes Nanog protein association with CD44 followed by Nanog activation and the expression of pluripotent stem cell regulators (e.g. Rex1 and Sox2). Nanog also forms a complex with the "signal transducer and activator of transcription protein 3" (Stat-3) in the nucleus leading to Stat-3-specific transcriptional activation and multidrug transporter, MDR1 (P-glycoprotein) gene expression. Furthermore, we observed that HA-CD44 interaction induces ankyrin (a cytoskeletal protein) binding to MDR1 resulting in the efflux of chemotherapeutic drugs (e.g. doxorubicin and paclitaxel (Taxol)) and chemoresistance in these tumor cells. Overexpression of Nanog by transfecting tumor cells with Nanog cDNA stimulates Stat-3 transcriptional activation, MDR1 overexpression, and multidrug resistance. Down regulation of Nanog signaling or ankyrin function (by transfecting tumor cells with Nanog small interfering RNA or ankyrin repeat domain cDNA) not only blocks HA/CD44-mediated tumor cell behaviors but also enhances chemosensitivity. Taken together, these findings suggest that targeting HA/CD44-mediated Nanog-Stat-3 signaling pathways and ankyrin/cytoskeleton function may represent a novel approach to overcome chemotherapy resistance in some breast and ovarian tumor cells displaying stem cell marker properties during tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00392-1 · Cited by 3,255
The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M., & Yamanaka, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00393-3 · Cited by 3,191
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109
Laurent, T. C., & Fraser, J. R. E. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.7.1563592 · Cited by 1,880
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Transcriptional Regulation of Nanog by OCT4 and SOX2
Rodda, D. J., Chew, J.-L., Lim, L.-H., Loh, Y.-H., Wang, B., Ng, H.-H., & Robson, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502573200 · Cited by 1,140
Signaling Properties of Hyaluronan Receptors
Turley, E. A., Noble, P. W., & Bourguignon, L. Y. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100038200 · Cited by 1,041
Self-citationGros, P., Croop, J., & Housman, D. (1986) · Cell · doi:10.1016/0092-8674(86)90594-5 · Cited by 1,031
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
Spectrin and Ankyrin-Based Pathways: Metazoan Inventions for Integrating Cells Into Tissues
Bennett, V., & Baines, A. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1353 · Cited by 930
p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression
Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., & Xu, Y. (2005) · Nature Cell Biology · doi:10.1038/ncb1211 · Cited by 859
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action
Stern, R., & Jedrzejas, M. J. (2006) · Chemical Reviews · doi:10.1021/cr050247k · Cited by 804
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together
Wang, T.-H., Wang, H.-S., & Soong, Y.-K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2619::aid-cncr26>3.0.co;2-j · Cited by 647
Underhill, C. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.293 · Cited by 609
Toole, B. P. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0244 · Cited by 570
Laurent, T. C., & Fraser, J. R. E. (1992) · PubMed · Cited by 550
Lux, S. E., John, K. M., & Bennett, V. (1990) · Nature · doi:10.1038/344036a0 · Cited by 527
Hyaluronan: a multifunctional, megaDalton, stealth molecule
Lee, J. Y., & Spicer, A. P. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00135-6 · Cited by 525
Hyaluronan-Cell Interactions in Cancer and Vascular Disease
Toole, B. P., Wight, T. N., & Tammi, M. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100039200 · Cited by 491
Octamer and Sox Elements Are Required for Transcriptional cis Regulation of Nanog Gene Expression
Kuroda, T., Tada, M., Kubota, H., Kimura, H., Hatano, S.-Y., Suemori, H., Nakatsuji, N., & Tada, T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2475-2485.2005 · Cited by 486
Microtubule-targeted anticancer agents and apoptosis
Bhalla, K. N. (2003) · Oncogene · doi:10.1038/sj.onc.1207233 · Cited by 461
Ezeh, U. I., Turek, P. J., Reijo, R. A., & Clark, A. T. (2005) · Cancer · doi:10.1002/cncr.21432 · Cited by 425
Signalling via integrins: Implications for cell survival and anticancer strategies
Hehlgans, S., Haase, M., & Cordes, N. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.09.001 · Cited by 373
West, D. C., & Kumar, S. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90428-x · Cited by 357
Burger, H., Foekens, J. A., Look, M. P., Gelder, M. E. M., Klijn, J. G. M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2003) · PubMed · Cited by 292
Mechetner, E. B., Kyshtoobayeva, A. S., Zonis, S., Kim, H. J., Stroup, R., Garcia, R., Parker, R. J., & Fruehauf, J. P. (1998) · PubMed · Cited by 291
Bourguignon, L. Y. W., Zhu, H., Shao, L., & Chen, Y. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1829 · Cited by 283
Self-citationBourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
Self-citationBourguignon, L. W., Zhu, H., Shao, L., & Chen, Y.-W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006498200 · Cited by 262
Self-citationTurkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7519 · Cited by 258
Huang, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2313 · Cited by 249
Misra, S., Ghatak, S., & Toole, B. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500737200 · Cited by 245
Screaton, G. R., Bell, M. V., Bell, J. I., & Jackson, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31376-0 · Cited by 243
Bourguignon, L. Y. W., Zhu, H., Chu, A., Iida, N., Zhang, L., & Hung, M.-C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27913 · Cited by 237
Self-citationBourguignon, L. Y. W., Singleton, P. A., Zhu, H., & Diedrich, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301885200 · Cited by 237
Self-citationBourguignon, L. Y. W., Singleton, P. A., Zhu, H., & Zhou, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204320200 · Cited by 224
Self-citationRegulation of Multidrug Resistance in Cancer Cells by Hyaluronan
Misra, S., Ghatak, S., Zoltan-Jones, A., & Toole, B. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300173200 · Cited by 221
The CD44 Receptor Interacts with P-Glycoprotein to Promote Cell Migration and Invasion in Cancer
Miletti-González, K. E., Chen, S., Muthukumaran, N., Saglimbeni, G. N., Wu, X., Yang, J., Apolito, K., Shih, W. J., Hait, W. N., & Rodrı́guez-Rodrı́guez, L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3478 · Cited by 207
Constitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma Cells
Huang, M., Page, C., Reynolds, R. K., & Lin, J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5931 · Cited by 189
Bourguignon, L. Y. W., Zhu, H., Zhou, B., Diedrich, F., Singleton, P. A., & Hung, M.-C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106759200 · Cited by 188
Self-citationSartor, C. I., Dziubinski, M. L., Yu, C., Jove, R., & Ethier, S. P. (1997) · PubMed · Cited by 184
Glutamylation of centriole and cytoplasmic tubulin in proliferating non-neuronal cells
Bobinnec, Y., Moudjou, M., Fouquet, J. P., Desbruyères, E., Eddé, B., & Bornens, M. (1998) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(1998)39:3<209::aid-cm4>3.0.co;2-# · Cited by 182
cDNA sequence for human erythrocyte ankyrin.
Lambert, S., Yu, H., Prchal, J. T., Lawler, J., Ruff, P., Speicher, D., Cheung, M. C., Kan, Y. W., & Palek, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1730 · Cited by 164
Peters, L. L., John, K. M., Lu, F. M., Eicher, E. M., Higgins, A., Yialamas, M., Turtzo, L. C., Otsuka, A. J., & Lux, S. E. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.313 · Cited by 163
Bourguignon, L. Y. W., Gilad, E., Rothman, K., & Peyrollier, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411985200 · Cited by 161
Self-citationBourguignon, L., Zhu, H., Shao, L., Zhu, D., & Chen, Y.-W. (1999) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(1999)43:4<269::aid-cm1>3.0.co;2-5 · Cited by 158
Self-citationWang, S. J., & Bourguignon, L. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.7.771 · Cited by 157
Self-citationOtto, E., Kunimoto, M., McLaughlin, T. M., & Bennett, V. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.114.2.241 · Cited by 153
CD44-Mediated Oncogenic Signaling and Cytoskeleton Activation During Mammary Tumor Progression
Bourguignon, L. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011371523994 · Cited by 152
Self-citationBourguignon, L., Gilad, E., & Peyrollier, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610054200 · Cited by 152
Self-citationRyanodine Receptor-Ankyrin Interaction Regulates Internal Ca2+ Release in Mouse T-lymphoma Cells
Bourguignon, L., Chu, A. J., Jin, H., & Brandt, N. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.17917 · Cited by 142
Self-citationThe Role and Regulation of Tumour‐Associated Hyaluronan
Knudson, W., Biswas, C., Li, X., Nemec, R. E., & Toole, B. P. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513774.ch10 · Cited by 141
Luciani, F., Molinari, A., Lozupone, F., Calcabrini, A., Lugini, L., Stringaro, A., Puddu, P., Arancia, G., Cianfriglia, M., & Fais, S. (2002) · Blood · doi:10.1182/blood.v99.2.641 · Cited by 138
New CD44 splice variants associated with human breast cancers
Iida, N., & Bourguignon, L. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620115 · Cited by 137
Self-citationAmstutz, P., Binz, H. K., Parizek, P., Stumpp, M. T., Kohl, A., Grütter, M. G., Forrer, P., & Plückthun, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501746200 · Cited by 137
NANOGP8 is a retrogene expressed in cancers
Zhang, J., Wang, X., Li, M., Han, J., Chen, B., Wang, B., & Dai, J. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05186.x · Cited by 134
Honig, S., Fu, S., Mao, X., Yopp, A. C., Gunn, M. D., Randolph, G. J., & Bromberg, J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316200 · Cited by 128
CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression
Bourguignon, L., Zhu, D., & Zhu, H. (1998) · Frontiers in bioscience · doi:10.2741/a308 · Cited by 124
Self-citationKordeli, E., & Bennett, V. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.114.6.1243 · Cited by 123
Lokeshwar, V. B., Iida, N., & Bourguignon, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23853 · Cited by 122
Self-citationCell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells
Vultur, A., Cao, J., Arulanandam, R., Turkson, J., Jove, R., Greer, P. A., Craig, A. W., Elliott, B. E., & Raptis, L. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207378 · Cited by 117
Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis
Kim, D. J., Chan, K. S., Sano, S., & DiGiovanni, J. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20342 · Cited by 117
Computational Model of Intracellular Pharmacokinetics of Paclitaxel
Kuh, H., Jang, S. H., Wientjes, M. G., & Au, J. L. ‐. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39296-1 · Cited by 116
Laßmann, S., Schuster, I., Walch, A. K., Göbel, H., Jütting, U., Makowiec, F., Hopt, U. T., & Werner, M. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.035113 · Cited by 114
Singleton, P. A., & Bourguignon, L. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.025 · Cited by 110
Self-citationAnkyrins: structure and function in normal cells and hereditary spherocytes.
Peters, L. L., & Lux, S. E. (1993) · PubMed · Cited by 108
Mapping the binding sites of human erythrocyte ankyrin for the anion exchanger and spectrin.
Davis, L. H., & Bennett, V. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86987-3 · Cited by 101
Bourguignon, L., Peyrollier, K., Gilad, E., & Brightman, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604672200 · Cited by 100
Self-citationThe Role of Hyaluronic Acid in Hemopoietic Stem Cell Biology
Haylock, D. N., & Nilsson, S. K. (2006) · Regenerative Medicine · doi:10.2217/17460751.1.4.437 · Cited by 94
Davis, L. H., Davis, J. Q., & Bennett, V. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37055-3 · Cited by 91
Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell
Ohashi, R., Takahashi, F., Cui, R., Yoshioka, M., Gu, T., Sasaki, S., Tominaga, S., Nishio, K., Tanabe, K. K., & Takahashi, K. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.025 · Cited by 89
Russo, R. I. C., García, M. G., Alaniz, L. D., Blanco, G. A. C., Álvarez, É., & Hajos, S. E. (2007) · International Journal of Cancer · doi:10.1002/ijc.23122 · Cited by 88
Wiseman, L. R., & Spencer, C. M. (1998) · Drugs & Aging · doi:10.2165/00002512-199812040-00005 · Cited by 84
Raft and cytoskeleton associations of an ABC transporter: P‐glycoprotein
Bacsó, Z., Nagy, H., Goda, K., Bene, L., Fenyvesi, F., Matkó, J., & Szabó, G. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20081 · Cited by 84
Serum hyaluronan (hyaluronic acid) in breast cancer patients
Delpech, B., Chevallier, B., Reinhardt, N., Julien, J., Duval, C., Maingonnat, C., Bastit, P., & Asselain, B. J. R. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460309 · Cited by 79
Zhu, D., & Bourguignon, L. (2000) · Journal of Cellular Physiology · Cited by 72
Self-citationStem Cells and Cancer: An Overview
Sales, K. M., Winslet, M. C., & Seifalian, A. M. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-9002-0 · Cited by 68
Iida, N., & Bourguignon, L. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199705)171:2<152::aid-jcp5>3.0.co;2-n · Cited by 66
Self-citationAuvinen, P., Tammi, R., Tammi, M., Johansson, R. T., & Kosma, V. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02220.x · Cited by 63
Singh, V. K., Zhou, Y., Marsh, J. A., Uversky, V. N., Forman-Kay, J. D., Liu, J., & Jia, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1820 · Cited by 62
Wang, S. J., & Bourguignon, L. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.1.19 · Cited by 54
Self-citationMDR1, Chemotherapy and chromatin remodeling
Baker, E. K., & El‐Osta, A. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.9.1101 · Cited by 48
Isolation and chromosomal localization of a novel nonerythroid ankyrin gene
Tse, W. T., Menninger, J. C., Yang‐Feng, T. L., et al. (1991) · Genomics · doi:10.1016/0888-7543(91)90173-c · Cited by 35
Cancer stem cells and individualized therapy.
Chumsri, S., Phatak, P., Edelman, M. J., Khakpour, N., Hamburger, A. W., & Burger, A. M. (2007) · PubMed · Cited by 26
Cell-Cell Fusion as a Means to Establish Pluripotency
Do, J. T., & Schöler, H. R. (2006) · Springer eBooks · doi:10.1007/3-540-31437-7_4 · Cited by 23
Cited by
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
Cancer Stem Cells: The Architects of the Tumor Ecosystem
Prager, B. C., Xie, Q., Bao, S., & Rich, J. N. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.009 · Cited by 587
Cancer stem cell (CSC) resistance drivers
Najafi, M., Mortezaee, K., & Majidpoor, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116781 · Cited by 466
Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer
Tavianatou, A. G., Caon, I., Franchi, M., Piperigkou, Z., Galesso, D., & Karamanos, N. K. (2019) · The FEBS Journal · doi:10.1111/febs.14777 · Cited by 462
Metadata
- Authors
- Bourguignon, L. Y. W., Peyrollier, K., Xia, W., & Gilad, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 283
- Issue
- 25
- Pages
- 17635-17651
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2012582486
- Cited by
- 442
- References
- 96
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.